NSNathan D. Schley

Nathan D. Schley

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nathan D. Schley has a total of 289 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Discovery of G2019S Mutant Selective LRRK2 Inhibitors Based on an Indazole Octahydrocyclopenta[ c ]pyrrole-Based Hybrid Chemotype

    by Upendra Rathnayake, Joseph D. Bungard, Mallory A. Maurer, Sri H. Kethanapalli, Christopher C. Presley, Sara Manore, Sichen Chang, Nathan D. Schley, Irene Zagol-Ikapitte, Katherine J. Watson, et al.

    LRRK2 is an important kinase target for Parkinson’s disease with disease-modifying potential. In this article, we report our efforts to identify indazole octahydrocyclopenta[c]pyrrole-based hybrid chemotypes as LRRK2 inhibitors utilizing a structure-guided hybridization approach. The initial set of compounds with a piperidine motif showed favorable potencies, but had a rather narrow selectivity window between wild-type and G2019S mutant LRRK2. In contrast, the replacement of the piperidine motif with an octahydrocyclopenta[c]pyrrole enhanced the selectivity window while maintaining good potencies. In short, the presented hybrid chemotype represented by 34 can serve as an alternative starting point and may enable the discovery of next-generation LRRK2 inhibitors through subsequent optimization campaigns.

  • Open Access

    De Novo Design in an M1 Positive Allosteric Modulator Backup Program: The Discovery of VU6069863

    by Changho Han, Upendra Rathnayake, Alison R. Gregro, Julie L. Engers, Christopher C. Presley, Nathan D. Schley, Analisa D. Thompson Gray, Michael Bubser, Hyekyung P. Cho, Alice L. Rodriguez, et al.

    Recently, we disclosed our M1 PAM that had advanced into Phase I clinical studies, VU0467319, as well as a deuterated back-up compound, VU6045422, to address a major metabolite produced in man and improve tox profile. Ultimately, this series failed to overcome its liabilities and was terminated. However, the team was challenged with developing chemically distinct backup candidates without performing a new HTS campaign. De novo design strategies based upon the other two M1 ago-PAMs that had previously entered clinical development, MK-7622 and TAK-071, led to the discovery of a fundamentally new chemotype based on a 3,4-dihydrobenzo[f][1,4]oxazepin-5-(2H)-one core, providing VU6069863. VU6069863 proved to be an M1 PAM (EC50 = 248 nM, 87% ACh Max) with minimal M1 agonism, (EC50 > 30 μM, 19% ACh Max) despite being derived from potent M1 ago-PAM chemotypes, with good CNS penetration (rat Kp = 0.59, Kp,uu = 0.13, MDCK-MDR1 ER = 1.8, Papp = 32.8 × 10–6 cm/s) and pro-cognitive efficacy in both contextual fear conditioning (minimally effective dose [MED] = 0.1 mg/kg PO) and novel object recognition (MED = 1 mg/kg PO) in rats.

  • Open Access

    Diastereoselective access to densely-functionalized azaspirobicyclic scaffolds from bicyclobutanes

    by Kushal Dhake, Muskan Sharma, Faith Alberts, Jaelyn Bjornerud-Brown, Kyla J. Woelk, Matthew O. Pohl, Odhran D. Cruise, Nathan D. Schley, David C. Leitch

    Imine addition to N -acylpyrazole substituted bicyclobutanes leads to spirocyclic beta-lactams that can be further converted to other spirocycles through skeletal rearrangements.

  • Open Access

    Terminal-Selective sp 3 C–H Borylation of Carbonyl Derivatives by a Di(pyridyl)arylmethane-Ligated Iridium Catalyst

    by Shuyao Zhang, Taylor M. Estock, Nathan D. Schley

    An iridium catalyst based on a 2,2'-dipyridylarylmethane ligand shows high activity at low catalyst loading for terminal sp3 C-H borylation of aliphatic carbonyl derivatives under conditions where the substrate is the limiting reagent. The site selectivity of the process is not directed by the functional group but, instead, by a preference for borylation of unhindered methyl groups over methylene or α-branched methyl groups. The active catalyst species are formed in situ from commercial precatalysts and a hydrosilane activator, with structural evidence provided by an isolable complex bearing a κ3-metalated ligand. The resulting alkylboronate esters are versatile reagents and are amenable to Pd-catalyzed B-alkyl Suzuki cross-coupling.


  • Phenoxy-Benzothiadiazole Donor–Acceptor Compounds Exhibit Solvatochromic Fluorescence and Are Precursors to Open-Shell Phenoxyl Radicals

    by Austin M. Stanley, Christopher Tremblay, Nathan D. Schley, Heather L. Buckley, David C. Leitch, Erin T. Chernick

    In this work, we present the synthesis of two highly fluorescent phenoxy-benzothiadiazole donor-acceptor (DA) compounds, which exhibit quantum yields of up to 84% in solution under an atmosphere of air. These compounds display solvatochromic fluorescence within the visible region of the electromagnetic spectrum, characteristic of DA exciplex behavior, and exhibit reversible reactivity under acidic conditions, as monitored by UV-vis spectroscopy. We demonstrate the reversible oxidation of the compound to the open-shell phenoxy radical 5•. In contrast, compound 6 undergoes irreversible oxidation to bis(quinone) 7, despite the loss of aromaticity. We also observe the comproportionation of 6 and 7 to compound 6• upon UV light irradiation in solution, as evidenced by EPR spectroscopy. The structures of compounds 5, 6, and 7 were confirmed through X-ray crystallography.


  • Open Access

    Sterically Stabilized Homoleptic Copper and Gold Allyl Complexes

    by Dillon Button-Jennings, Nathan D. Schley, Timothy P. Hanusa

    Well-defined allyl derivatives of the coinage metals remain rare, often owing to their thermal and redox sensitivity. We report the isolation of a potassium bis­(allyl)­cuprate, [KCuA′2] (A′ = 1,3-(SiMe3)2C3H3), prepared with either solution or mechanochemical methods, which is stable at room temperature in both the solid state and solution. In the solid state, it crystallizes as a dimer ([{KCuA′2}2]), featuring a planar K2Cu2 core and η1-bound allyl ligands. In neat hexanes, [{KCuA′2}2] enables conjugate (1,4)-allylation of α,β-unsaturated ketones. It does not transmetallate when treated with lithium or sodium salts but converts to the crystallographically authenticated, but less stable neutral tetramer, [{CuA′}4], which possesses μ-η:1η2 allyl bridges and a puckered Cu4 ring. Gold analogs of both the anionic and neutral complexes have also been prepared ([{KAuA′2}2] and [{AuA′}4], respectively) and are structurally similar to their copper counterparts. However, the potassium bis­(allyl)­aurate does not perform the same addition chemistry as its copper analogue. DFT calculations on the unsubstituted di­(allyl) cuprates (i.e., [{(Li,K)­Cu­(C3H5)2}2]) suggest that both the trimethylsilyl groups and the substitution of Li+ with K+ influence the aggregation of potassium bis­(allyl)­cuprate. These findings provide structural and reactive benchmarks for coinage-metal allyl complexes.

  • Open Access

    Homoleptic biisoquinolinedioxide lanthanide complexes for near-infrared circularly polarized luminescence

    by Douglas Kariuki Mundia, Ashley Schmidt, Jerome R. Robinson, Nathan D. Schley, Gaël Ung

    Coordination of axially chiral 1,1′-biisoquinoline- N , N ′-dioxide ligands to lanthanide ions (Yb, Er) yield 8-coordinate D 2 -symmetrical species exhibiting circularly polarized luminescence in the near-infrared region.


  • Open Access

    Phenoxy-Benzothiadiazole Donor-Acceptor Compounds Exhibit Solvatochromic Fluorescence and Are Precursors to Open-Shell Phenoxyl Radicals

    by Austin Stanley, Christopher Tremblay, Nathan Schley, Heather Buckley, David Leitch, Erin Chernick

    In this work, we present the synthesis of two highly fluorescent phenoxy-benzothiadiazole donor-acceptor (DA) compounds, which exhibit quantum yields of up to 84% in solution under an atmosphere of air. These compounds display solvatochromic fluorescence within the visible region of the electromagnetic spectrum, characteristic of DA exciplex behavior, and exhibit reversible reactivity under acidic conditions as monitored by UV-Vis spectroscopy. We demonstrate the reversible oxidation of compound to the open-shell phenoxy radical 5·. In contrast, compound 6 undergoes irreversible oxidation to bis(quinone) 7, despite the loss of aromaticity. We also observe the comproportionation of 6 and 7 to compound 6· upon UV light irradiation in solution, as evidenced by EPR spectroscopy. The structures of compounds 5, 6, and 7 were confirmed through X-ray crystallography.

  • Open Access

    Tandem Oligomerization-Hydrogenation Using Brønsted Acidic Iridium Hydride Catalysts

    by Austin J. Leitgeb, Scott M. Chapp, Caleb D. Fast, Kathryn E. Fink, Nathan D. Schley

    Cationic iridium complexes bearing the tris­[3,5-bis­(trifluoromethyl)­phenyl]­phosphine ligand unexpectedly give acidic metal hydrides. Net-dihydrogen heterolysis at such complexes provides hydrogenation catalysis by an ionic mechanism. The direct reduction of isobutene competes with cationic oligomerization to give the gasoline additive isooctane (2,4,4-trimethylpentane) as a major product of a tandem oligomerization/hydrogenation sequence. Mechanistic experiments argue for the role of neutral iridium hydrides generated by the proton transfer of a cationic hydride precursor to an olefin substrate.


  • Open Access

    Unlocking Chromium Decarboxylative Ligand-to-Metal Charge Transfer: Efficient and Redox-Neutral Allylation of Aldehydes Using Carboxylic Acids

    by Supeng Wu, Ziqi Jiao, Alex T. Sung, Abigail B. Faulhaber, Nathan D. Schley, Alexander W. Schuppe

    Here, we report the light-induced decarboxylative ligand-to-metal charge transfer (LMCT) of Cr(III) carboxylate complexes and demonstrate its applicability toward stereoselective Nozaki-Hiyama-Kishi (NHK) allylation reactions. The critical design element of our reaction was identifying a bipyridyl ligand scaffold that enables a single Cr catalyst to facilitate both photolytic dissociation and aldehyde addition. This approach allows for the direct utilization of carboxylic acids and eliminates the need for external redox reagents. The broad utility of this protocol was demonstrated by the preparation of a variety of homoallylic alcohols in good yields and diastereoselectivities as well as the identification of advantageous retrosynthetic disconnections. Extensive studies supported the LMCT mechanism of this transformation, including the characterization of the catalytically active Cr-carboxylate species.